组织陈列-产品详情

home > TISSUE ARRAYS > Baldder > UBD641

Type
- FFPE
- FROZEN TISSUE
Identity
Organ
- Liver
- Esophagus
- Ovary
- Stomach
- Lung
- Colon
- Rectum
- Kidney
- Breast
- Endometrium
- Uterus
- Bladder
- Pancreas
- Skin
- Penis
- Testis
- Soft_Tissue
- Bone/Cartilage
- Oral/Cavity
- Bone/Marrow
- Heart
- Spleen
- Head/Neck
- Vulva
- Melanoma
- Appendix
- Intestine
- Adrenal Gland
- Thymus
- Fallopian tube
- Mouse
- Fetus
- Rat
- Monkey (Rhesus) (Normal)-RsFPT
- Monkey (Cynomolgus) (Normal)-CyFPT
- Dog
- Multiple organ
- Gall bladder and bile duct
- Esophagogastric junction
Types/Disease
Cores
Cases

Cores:

64

CASES:

64

Core Diameter(mm):

2

Thickness(µm):

5

Row number:

8

Column number:

8

Tissue Array Type:

FFPE

Species:

Human

UBD641

$225.00

Add To Collect

Description: Urothelial carcinoma tissue array, including pathology grade, TNM and clinical stage, 64 cases/64 cores

Details: Urothelial carcinoma tissue microarray, containing 64 urothelial carcinoma, single cores per case

Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

Please Select Tissue Array Type:

Unstained

H&E

Tag:

64 Cores 64 Cases Baldder special price single core per case

Add To Cart

Outright purchase

Note

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

Specification sheet
Overlapping case
Download specifications

Legend:

Car-Cardia Eso-Fsophagus

Malignant(-)
Malignant(I)
Malignant(II)
Malignant(III)

TISSUE ARRAYS
UBD641

	1	2	3	4	5	6	7	8
A	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
B	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
C	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
D	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
E	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
F	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
G	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
H	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla

UBD641

Age:
Sex:
Organ/Anatomic Site:
Pathology diagnosis:
Grade:
TNM:
Stage:
Tissue ID.:
Type:

Pos	No.	Age	Sex	Organ/Anatomic Site	Pathology diagnosis	Grade	TNM	Stage	Type
A1	1	76	M	Bladder	Urothelial carcinoma	3	T2N0M0	II	Malignant
A2	2	71	M	Bladder	Urothelial carcinoma	1	T2bN0M0	II	Malignant
A3	3	78	M	Bladder	Urothelial carcinoma	3	T3bN0M0	III	Malignant
A4	4	61	M	Bladder	Urothelial carcinoma	2	T2N0M0	II	Malignant
A5	5	56	M	Bladder	Urothelial carcinoma	2	T1N0M0	I	Malignant
A6	6	52	M	Bladder	Urothelial carcinoma	3	T3N0M0	III	Malignant
A7	7	76	M	Bladder	Urothelial carcinoma	2	T1N0M0	I	Malignant
A8	8	80	M	Bladder	Urothelial carcinoma	3	T3N0M0	III	Malignant
B1	9	79	F	Bladder	Urothelial carcinoma	2	T2N0M0	II	Malignant
B2	10	63	M	Bladder	Urothelial carcinoma	2	T2aN0M0	II	Malignant
B3	11	46	M	Bladder	Urothelial carcinoma	1	T2N0M0	II	Malignant
B4	12	48	F	Bladder	Urothelial carcinoma	3	T2bN0M0	II	Malignant
B5	13	56	F	Bladder	Urothelial carcinoma	2	T2bN0M0	II	Malignant
B6	14	45	M	Bladder	Urothelial carcinoma	3	T2bN0M0	II	Malignant
B7	15	68	M	Bladder	Urothelial carcinoma	3	T1N0M0	I	Malignant
B8	16	37	F	Bladder	Urothelial carcinoma	2	T2bN0M0	II	Malignant
C1	17	54	M	Bladder	Urothelial carcinoma	3	T2N0M0	II	Malignant
C2	18	73	F	Bladder	Urothelial carcinoma	3	T2N0M0	II	Malignant
C3	19	37	F	Bladder	Urothelial carcinoma	2	T1N0M0	I	Malignant
C4	20	58	M	Bladder	Urothelial carcinoma	3	T1N0M0	I	Malignant
C5	21	65	M	Bladder	Urothelial carcinoma	2	T2N0M0	II	Malignant
C6	22	50	F	Bladder	Urothelial carcinoma	2	T2N0M0	II	Malignant
C7	23	70	M	Bladder	Urothelial carcinoma	2	T2N0M0	II	Malignant
C8	24	57	F	Bladder	Urothelial carcinoma	3	T3N0M0	III	Malignant
D1	25	77	F	Bladder	Urothelial carcinoma	2	T1N0M0	I	Malignant
D2	26	61	M	Bladder	Urothelial carcinoma	3	T2N0M0	II	Malignant
D3	27	51	M	Bladder	Urothelial carcinoma	1	T1N0M0	I	Malignant
D4	28	70	M	Bladder	Urothelial carcinoma	2	T2N0M0	II	Malignant
D5	29	66	M	Bladder	Urothelial carcinoma	3	T2bN0M0	II	Malignant
D6	30	78	F	Bladder	Urothelial carcinoma	2	T1N0M0	I	Malignant
D7	31	61	F	Bladder	Urothelial carcinoma	2	T2N0M0	II	Malignant
D8	32	70	M	Bladder	Urothelial carcinoma	2	T1N0M0	I	Malignant
E1	33	46	M	Bladder	Urothelial carcinoma	3	T2N0M0	II	Malignant
E2	34	45	F	Bladder	Urothelial carcinoma	3	T3N0M0	III	Malignant
E3	35	52	M	Bladder	Urothelial carcinoma	2	T2N0M0	II	Malignant
E4	36	65	M	Bladder	Urothelial carcinoma	2	T1N0M0	I	Malignant
E5	37	61	F	Bladder	Urothelial carcinoma	1	T1N0M0	I	Malignant
E6	38	72	M	Bladder	Urothelial carcinoma	1	T1N0M0	I	Malignant
E7	39	56	M	Bladder	Urothelial carcinoma	1	-	-	Malignant
E8	40	70	M	Bladder	Urothelial carcinoma	2	T1N0M0	I	Malignant
F1	41	71	M	Bladder	Urothelial carcinoma	1	T2N0M0	II	Malignant
F2	42	70	M	Bladder	Urothelial carcinoma	3	T3bN0M0	III	Malignant
F3	43	65	M	Bladder	Urothelial carcinoma	2	T1N0M0	I	Malignant
F4	44	35	M	Bladder	Urothelial carcinoma	2	T2aN0M0	II	Malignant
F5	45	50	M	Bladder	Urothelial carcinoma	2	T2N0M0	II	Malignant
F6	46	63	M	Bladder	Urothelial carcinoma	2	T1N0M0	I	Malignant
F7	47	74	M	Bladder	Urothelial carcinoma	2	T2N0M0	II	Malignant
F8	48	66	M	Bladder	Urothelial carcinoma	2	T2N0M0	II	Malignant
G1	49	64	M	Bladder	Urothelial carcinoma	2	T1N0M0	I	Malignant
G2	50	70	M	Bladder	Urothelial carcinoma	2	T2aN0M0	II	Malignant
G3	51	68	M	Bladder	Urothelial carcinoma	2	T1N0M0	I	Malignant
G4	52	74	F	Bladder	Urothelial carcinoma	2	T2bN0M0	II	Malignant
G5	53	60	M	Bladder	Urothelial carcinoma	3	T1N0M0	I	Malignant
G6	54	52	F	Bladder	Urothelial carcinoma	2	T1N0M0	I	Malignant
G7	55	76	M	Bladder	Urothelial carcinoma	2	T2N0M0	II	Malignant
G8	56	38	M	Bladder	Urothelial carcinoma	2	-	-	Malignant
H1	57	67	M	Bladder	Urothelial carcinoma	2	T1N0M0	I	Malignant
H2	58	45	M	Bladder	Urothelial carcinoma	3	T1N0M0	I	Malignant
H3	59	47	F	Bladder	Urothelial carcinoma	2	T2bN0M0	II	Malignant
H4	60	61	F	Bladder	Urothelial carcinoma	3	T3aN0M0	III	Malignant
H5	61	76	F	Bladder	Urothelial carcinoma	3	T1N0M0	I	Malignant
H6	62	71	M	Bladder	Urothelial carcinoma	2	-	-	Malignant
H7	63	76	M	Bladder	Urothelial carcinoma	2	T3aN0M0	III	Malignant
H8	64	58	M	Bladder	Urothelial carcinoma	2	T2N0M0	II	Malignant

Find overlapping cases with this tissue array:

UBD641

File Format: .xlsx

Release Date: 2025-01-17 16:11:47
Download

	1	2	3	4	5	6	7	8
A	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
B	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
C	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
D	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
E	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
F	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
G	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
H	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla

	1	2	3	4	5	6	7	8
A	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
B	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
C	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
D	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
E	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
F	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
G	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
H	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla

	1	2	3	4	5	6	7	8
A	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
B	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
C	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
D	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
E	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
F	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
G	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
H	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla